πŸ‡ΊπŸ‡Έ FDA
Patent

US 10351547

Somatostatin modulators and uses thereof

granted A61PA61P11/00A61P13/12

Quick answer

US patent 10351547 (Somatostatin modulators and uses thereof) held by CRINETICS PHARMACEUTICALS, INC. expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CRINETICS PHARMACEUTICALS, INC.
Grant date
Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P11/00, A61P13/12, A61P25/00, A61P25/04